• Exclusive Insights on mHSPC Treatment: Interview with Dr. Fred Saad

    In a recent Media Medic interview, our colleague El Bachir MOURABIT had the privilege to speak with Dr. Fred Saad about breakthrough advancements in metastatic hormone-sensitive prostate cancer (mHSPC) treatment. Dr. Saad emphasized the importance of combining androgen deprivation therapy (ADT) with ARPIs like apalutamide, enzalutamide, or abiraterone for improved survival. He also shared promising…

  • Dr. Shahrukh Hashmi: Opening Pandora’s Box, Challenges in Long-Term Monitoring After CAR-T Therapy

    As a shining new star in the medical field, CAR-T cell therapy, while significantly effective, is filled with unknowns much like Pandora’s Box. From successful treatment to long-term monitoring, every step requires meticulous planning. Recently, at the 12th Lu Daopei Hematology Academic Forum, Hematology Frontier had the honor of inviting Dr. Shahrukh Hashmi from the…

  • SOHO 2024 | Dr. Valeria Santini: Imetelstat Demonstrates Durable Efficacy in the Treatment of LR-MDS

    Low-risk myelodysplastic syndromes (LR-MDS) are complex blood disorders characterized by the abnormal proliferation and dysfunction of marrow cells, leading to increased risks of anemia, bleeding, and infection. Although the progression of LR-MDS is relatively slow, the treatment of this disease still faces significant challenges. Existing therapeutic options, such as erythropoiesis-stimulating agents (ESAs) and immunomodulators, may…

  • Shaping the Future of Lung Cancer Care: Dr. Caicun Zhou on IASLC’s 50th Anniversary and the Promise of HARMONi2

    The International Association for the Study of Lung Cancer (IASLC), founded in 1974, has grown into a global organization with over 10,000 members from more than 100 countries and regions. In 2023, Dr. Caicun Zhou from Shanghai Pulmonary Hospital, Tongji University School of Medicine was elected as the IASLC President-Elect for 2023-2025 and will serve…

  • From Curious Learner to Pioneer: Dr. Jie Chen’s Medical Evolution

    As we step further into the 21st century, the field of medicine has undergone tremendous changes. Among the many advancements, a generation of compassionate and skilled doctors has emerged, dedicated to the wellbeing of their patients and their nation. The phrase “a doctor’s heart is like a parent’s” perfectly captures this essence. In the Oncology…

  • Serum Albumin as a Prognostic Factor in Acute Myeloid Leukemia

    In June 2024, Blood Science published a pivotal study led by Dr. Hui Wei from the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , investigating the prognostic significance of serum albumin levels in patients with acute myeloid leukemia (AML). AML is a highly aggressive hematological…

  • Plerixafor-Based Mobilization and Increased Mononuclear Cell Counts: Risk Factors for Engraftment Syndrome Post-Autologous Hematopoietic

    In June 2024, Blood Science published a significant study led by Dr. Xiaohui Zhang and colleagues from the Peking University People’s Hospital, focusing on the incidence and risk factors of engraftment syndrome (ES) following autologous hematopoietic stem cell transplantation (ASCT) in the era of plerixafor-based mobilization. ASCT remains a critical therapy for hematologic malignancies, particularly…

  • 2024 Nobel Prize | MicroRNAs (miRNAs) and Liver Diseases

    RNAs serve diverse functions, with one of the key roles being to guide protein synthesis, which is fundamental to life. MicroRNAs are a class of endogenous non-coding RNAs that play…